Literature DB >> 15192009

Potential role for sildenafil in the management of perioperative pulmonary hypertension and right ventricular dysfunction after cardiac surgery.

B P Madden, A Sheth, T B L Ho, J E S Park, R R Kanagasabay.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15192009     DOI： 10.1093/bja/aeh571

Source DB:  PubMed          Journal:  Br J Anaesth        ISSN： 0007-0912            Impact factor:   9.166


× No keyword cloud information.
  7 in total

Review 1.  A Practical Clinical Approach to the Diagnosis and Treatment of Patients with Pulmonary Hypertension.

Authors:  Brendan P Madden
Journal:  Eur Cardiol       Date:  2015-12

Review 2.  Pulmonary Hypertension.

Authors:  Brendan P Madden
Journal:  Eur Cardiol       Date:  2015-07

3.  Sildenafil citrate and sildenafil nitrate (NCX 911) are potent inhibitors of superoxide formation and gp91phox expression in porcine pulmonary artery endothelial cells.

Authors:  Saima Muzaffar; Nilima Shukla; Amit Srivastava; Gianni D Angelini; Jamie Y Jeremy
Journal:  Br J Pharmacol       Date:  2005-09       Impact factor: 8.739

Review 4.  Pulmonary function tests.

Authors:  Harpreet Ranu; Michael Wilde; Brendan Madden
Journal:  Ulster Med J       Date:  2011-05

Review 5.  Pulmonary vascular and right ventricular dysfunction in adult critical care: current and emerging options for management: a systematic literature review.

Authors:  Laura C Price; Stephen J Wort; Simon J Finney; Philip S Marino; Stephen J Brett
Journal:  Crit Care       Date:  2010-09-21       Impact factor: 9.097

Review 6.  Hospital and intensive care unit management of decompensated pulmonary hypertension and right ventricular failure.

Authors:  Angel Coz Yataco; Melina Aguinaga Meza; Ketan P Buch; Margaret A Disselkamp
Journal:  Heart Fail Rev       Date:  2016-05       Impact factor: 4.214

7.  Additive effect of phosphodiesterase inhibitors in control of pulmonary hypertension after congenital cardiac surgery in children.

Authors:  Peiravian Farah; Amirghofran Ahmad-Ali; Ghamsari Hanane; Emaminia Abbas
Journal:  Iran J Pediatr       Date:  2013-02       Impact factor: 0.364
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.